Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer. GFPC 99-01 study (Groupe français de pneumo-cancérologie)

Lung Cancer

Volumn 51, Issue 1, 2006, Pages 105-114

  Thomas, P ^a,e   Robinet, G ^b   Gouva, S ^b   Fournel, P ^c   Lena H ^d   Le Caer, H ^e   Perol, M ^f   Berard, H ^g   Bombaron, P ^h   Vergnenegre, A ⁱ   Kleisbauer, J P ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

^b CHU MORVAN   (France)

^c HÔPITAL NORD   (France)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e CENTRE HOSPITALIER   (France)

^f CROIX ROUSSE HOSPITAL   (France)

^g HÔPITAL D'INSTRUCTION DES ARMÉES ROBERT PICQUÉ   (France)

^h CENTRE HOSPITALIER DE MULHOUSE   (France)

ⁱ Hopital du Cluzeau   (France)

Author keywords

Advanced non small cell lung cancer; Carboplatin; Chemotherapy; Cisplatine; Gemcitabine; Phase II; Randomized; Vinorelbine

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE; NAVELBINE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; ASTHENIA; BLEEDING; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; FOLLOW UP; HEART DISEASE; HUMAN; HUMAN TISSUE; INFECTION; LIVER DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NAUSEA; NEUROPATHY; NEUTROPENIA; PLEURA EFFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; RIBONUCLEOTIDE REDUCTASES; TREATMENT OUTCOME; VINBLASTINE;

EID: 30644463523     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2005.10.004     Document Type: Article

References (31)

1. P.J. Souquet, F. Chauvin, J.P. Boissel, R. Cellerino, Y. Cormier, and P.A. Ganz Polychemotherapy in advanced non-small cell lung cancer: a meta-analysis Lancet 342 1993 19 21
2. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials Br Med J 311 1995 899 909
3. M.H. Cullen, R. Joshi, A.D. Chetiyawardana, and C.M. Woodroffe Mitomycin, ifosfamide and cisplatin in non small cell lung cancer: treatment good enough to compare Br J Cancer 58 1998 359 361
4. M.G. Kris, R.J. Gralla, M.S. Wertheim, D.P. Kelsen, J.P. O'Connell, and M.T. Burke Trial of the combination of mitomycin, vindesine and cisplatin in patients with advanced non-small cell lung cancer Cancer Treat Rep 70 1986 1091 1096
5. T. Le Chevalier, D. Brisgand, J.Y. Douillard, J.L. Pujol, V. Alberola, and A. Monnier Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients J Clin Oncol 12 1994 360 367
6. F.A. Shepherd Current paradigms in first-line treatment of non-small-cell lung cancer Oncology (Huntingt) 18 8 Suppl 5 2004 13 20
7. C. Manegold Gemcitabine (Gemzar) in non-small cell lung cancer Expert Rev Anticancer Ther 4 3 2004 345 360
8. T. Le Chevalier, M. Gottfried, U. Gatzemeier, F. Shepherd, P. Weynants, and B. Cottier A phase II study of gemcitabine in non-small-cell lung cancer Bull Cancer 84 3 1997 382 388
9. D. Castellano, P. Lianes, L. Paz-Ares, M. Hidalgo, J.A. Guerra, and C. Gomez-Martin A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer Ann Oncol 9 4 1998 457 459
10. F. Cardenal, M.P. Lopez-Cabrerizo, A. Anton, V. Alberola, B. Massuti, and A. Carrato Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatine in the treatment of locally advanced or metastatic non-small-cell lung cancer J Clin Oncol 17 1 1999 12 18
11. L. Crino, G. Scagliotti, M. Marangolo, F. Figoli, M. Clerici, and F. De Marinis Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study J Clin Oncol 15 1 1997 297 303
12. R. Abratt, W. Bezwoda, L. Goedhals, and D. Hacking Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer J Clin Oncol 15 2 1997 744 749
13. L.H. Einhorn Phase II trial of gemcitabine plus cisplatine in non-small cell lung cancer: a Hoosier Oncology Group study Semin Oncol 24 3 suppl 8 1997 S8-24 S8-26
14. F.A. Shepherd, Y. Cormier, R. Burkes, W.K. Evans, G. Goss, and P. Klimo Phase II trial of gemcitabine and weekly cisplatin for advanced non-small cell lung cancer. Semin Oncol 24 3 suppl 8 1997 S8-27 S8-30
15. P. Thomas, G. Robinet, R.M. Ferri-Dessens, H. Lena, S. Gouva, and J.M. Vernejoux Phase I trial of gemcitabine and carboplatin in metastatic non small cell lung cancer: a Groupe Francais de Pneumologie Cancérologie Digestive Study Lung Cancer 36 2002 191 198
16. A. Depierre, C. Chastang, E. Quoix, B. Lebeau, F. Blanchon, and N. Paillot Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial Ann Oncol 5 1994 37 42
17. T.R. Fleming One sample multiple testing procedure for phase II clinical trials Biometrics 38 1982 143 151
18. A.H. Calvert, D.R. Newell, L.A. Gumbrell, S. O'Reilly, M. Burnell, and F.E. Boxall Carboplatin dosage: prospective evaluation of a simple formula based on renal function J Clin Oncol 7 1989 1748 1756
19. D.W. Cockcroft Gault MH: prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
20. C.F. Mountain Revisions in the international system for staging lung cancer Chest 111 1997 1710 1717
21. S. Danson, M.R. Middleton, K.J. O'Byrne, M. Clemons, M. Ranson, and J. Hassan Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide and cisplatin or mitomycin, vinblastine and cisplatin in patients with advanced non small cell lung carcinoma Cancer 98 3 2003 542 553
22. P. Zatloukal, L. Petruzelka, M. Zemanova, V. Kolek, J. Skrickova, and M. Pasek Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIB and IV non small cell lung cancer: a phase III randomised trial Lung Cancer 41 2003 321 331
23. P. Mazzanti, C. Massacesi, M.B.L. Rocchi, R. Mattioli, P. Lippe, and R. Trivisonne Randomized multicenter phase II study of gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in patients with advanced non small cell lung cancer Lung Cancer 41 2003 81 89
24. A.C. Grigorescu, I.N. Draghici, C. Nitipir, N. Gutulescu, and E. Corlan Gemcitabine and carboplatin versus cisplatin and vinblastine in advanced non small cell lung cancer stages III and IV: a phase III randomised trial Lung Cancer 37 2002 9 14
25. R.M. Rudd, N.H. Gower, S.G. Spiro, T.G. Eisen, P.G. Harper, and J.A.H. Littler Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group J Clin Oncol 23 1 2005 142 153
26. M. Neubauer, R. Heaven, J. Olivares, A. Otsuka, E. Paschold, and C. Sirridge Results of a phase II study of carboplatin plus gemcitabine in patients with untreated extensive small cell lung cancer Lung Cancer 46 2004 369 375
27. Carrato A, Garcia-Gomez J, Alberola V, et al. Carboplatin (CARBO) in combination with gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC). Comparison of two consecutive phase II trials using different schedules. In: ASCO Proceedings, 1999, p. 498a [abstract 1922].
28. A. Masotti, G. Zannini, and A. Gentile Activity of gemcitabine and carboplatin in advanced non small cell lung cancer: a phase II trial Lung Cancer 36 2002 99 103
29. C. Korsik, P. Albrecht, and A. Elmer Gemcitabine and carboplatin in patients with locally advanced or metastatic non small cell lung cancer: a prospective phase II study Lung cancer 40 2003 85 90
30. T. Le Chevalier, G. Scagliotti, R. Natale, S. Danson, R. Rosell, and R. Stahel Efficacy of gemcitabin plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a metanalysis of survival outcomes Lung cancer 47 2005 69 80
31. I. Maestu, L. Gomez-Aldaravi, M.D. Torregrosa, C. Camps, C. Llorca, and C. Bosch Gemcitabine and low dose carboplatin in the treatment of elderly patients with advanced non-small cell lung cancer Lung cancer 42 2003 345 354